Epidemiological study on herpes zoster

Epidemiological study on herpes zoster - Epidemiological study on herpes zoster

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005356

Enrollment

12000

Registered

2011-03-31

Start date

2008-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Those who meet the following requirements as of October 1st, 2008. There is no upper age limit. Subject A : 50 or older Subject B : 50 or older Subject C : 60 or older Subject C' : 60 or older 2.Those who possess Japanese citizenship and live in Shozu, Kagawa as of October 1st, 2008. 3.Those who give consent in writing to cooperate on this study.

Exclusion criteria

Exclusion criteria: Participants enrolled in Subject B, C or C' may not be accepted, if they meet the following items on the day varicella intradermal skin reaction is evaluated. 1.Those who with epidemic dermatosis. 2.Other than above, those who are not suitable for varicella intradermal skin test or blood sampling. Some participants may not be enrolled when the organizers consider they are inappropriate even they meet the above criteria.

Design outcomes

Primary

Measure	Time frame
-The number of patients developed herpes zoster -Degree of pain by 6-level face scale -Duration of pain -Health questionnaire of 31 items -Level of cell-mediated immunity by varicella intradermal skin test (at baseline, 1 year later, 2 years later and 3 years later) -Level of cell-mediated immunity by ELISPOT (at baseline, 1 year later, 2 years later, 3 years later, in onset and at the recovery) -Level of humoral immunity by gp-ELISA, IAHA and NT (at baseline, 1 year later, 2 years later, 3 years later, in onset and at the recovery)	—

Measure

Time frame

-The number of patients developed herpes zoster -Degree of pain by 6-level face scale -Duration of pain -Health questionnaire of 31 items -Level of cell-mediated immunity by varicella intradermal skin test (at baseline, 1 year later, 2 years later and 3 years later) -Level of cell-mediated immunity by ELISPOT (at baseline, 1 year later, 2 years later, 3 years later, in onset and at the recovery) -Level of humoral immunity by gp-ELISA, IAHA and NT (at baseline, 1 year later, 2 years later, 3 years later, in onset and at the recovery)

—

Countries

Japan

Contacts

Public ContactKimihiko Yoshii

National Institute of Biomedical Innovation Department of Strategic Planning

k-yoshii@nibio.go.jp072-641-9832

Outcome results